Evidence map›Paper›PMID 33481063›Full record

ReviewDer Urologe. Ausg. A2021

[Quality assessment of radical cystectomy-opportunities, risks, challenges].

F Roghmann, J Breyer, M Kriegmair, F Wezel, M Burger, J Noldus, C Bolenz, Bladder Cancer Research Initiative for Drug Targets Germany (BRIDGE) Consortium e. V.

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Carbon ion radiotherapy for bladder cancer: A case report.World journal of clinical cases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

F RoghmannKlinik für Urologie und Neuro-Urologie, Universitätsklinikum der Ruhr-Universität Bochum, Marien Hospital, 44625, Herne, Deutschland. florian.roghmann@rub.de.
J BreyerKlinik für Urologie der Universität Regensburg, Caritas-Krankenhaus St. Josef, Regensburg, Deutschland.
M KriegmairKlinik für Urologie, Universitätsklinikum Mannheim, Mannheim, Deutschland.
F WezelKlinik für Urologie und Kinderurologie, Universitätsklinikum Ulm, Ulm, Deutschland.
M BurgerKlinik für Urologie der Universität Regensburg, Caritas-Krankenhaus St. Josef, Regensburg, Deutschland.
J NoldusKlinik für Urologie und Neuro-Urologie, Universitätsklinikum der Ruhr-Universität Bochum, Marien Hospital, 44625, Herne, Deutschland.
C BolenzKlinik für Urologie und Kinderurologie, Universitätsklinikum Ulm, Ulm, Deutschland.
Bladder Cancer Research Initiative for Drug Targets Germany (BRIDGE) Consortium e. V.
Caritas-Krankenhaus St. Josef · DEUniversitätsklinik Marien Hospital Herne · DEUniversity Hospital Ulm · DEUniversity Medical Centre Mannheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radical cystectomy (RC) is the standard treatment for nonmetastatic muscle-invasive urothelial carcinoma of the urinary bladder. It is associated with relevant morbidity and mortality. After RC, the 5‑year overall survival rate is approximately 60%. In the context of the present work, quality parameters of RC divided into oncological/functional criteria and freedom from complications are identified and summarized. A PubMed search was performed. In addition to early criteria such as negative surgical margins, performance of pelvic lymphadenectomy, creation of a continent urinary diversion or preservation of sexual function, long-term criteria were identified such as the absence of higher-grade postoperative complications, recurrence-free survival and the preservation of health-related quality of life. The early criteria are suitable for individualized therapy planning, whereas the long-term criteria can be used for quality monitoring.

Indexed as

Urinary Bladder NeoplasmsUrinary DiversionCystectomyHumansQuality of LifeTreatment OutcomeBladder cancerQuality assessmentQuality of lifeTreatment outcomeUrinary diversion

Identifiers

PMID33481063
OpenAlexW3121400649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.